METTL3 Promotes Oxaliplatin Resistance of Gastric Cancer CD133⁺ Stem Cells by Promoting PARP1 mRNA Stability

The in vitro and in vivo results indicated that CD133⁺ stem cell-like cells are the main subpopulation and PARP1 was the central gene mediating oxaliplatin resistance in gastric cancer.